Paper
0
Interleukin(IL)-1/IL-6-inhibitor-associated drug reaction with eosinophilia and systemic symptoms (DReSS) in systemic inflammatory illnesses
Authors
Vivian Saper,Lü Tian
Ruud Verstegen,C. Conrad,Michal Cidon,Rachel Hopper,Christin Kuo,Kazutoyo Osoegawa,Kevin Baszis,Catherine Bingham,Ian Ferguson,Timothy Hahn,AnnaCarin Horne,E.A. Isupova,Jordan Jones,Özgür Kasapçopur,Marisa Klein-Gitelman,М. Костик,Seza Özen,Omkar Phadke,Sampath Prahalad,Rachel Randell,Cory Stingl,Rabheh Abdul‐Aziz,Shoghik Akoghlanian,Dalila Julandani,M. Alvarez,Brigitte Bader‐Meunier,Erin Balay‐Dustrude,Imelda Balboni,Sarah Baxter,Roberta Berard,Sagar Bhattad,Roxana Bolaria,Alexis Boneparth,Elaine Cassidy,Dominic Co,K. Collins,Paul Dancey,Anne Dickinson,Barbara Edelheit,Graciela Espada,Edel Flanagan,Lisa Imundo,Ankur Jindal,Hyoun‐Ah Kim,Günter Klaus,Carol Lake,William Lapin,Erica Lawson,Itay Marmor,Joy Mombourquette,Benson Ogunjimi,Remigio Olveda,Michael Ombrello,Karen Onel,Catherine Poholek,Athimalaipet Ramanan,Angelo Ravelli,Adam Huber,Athena Robinson,Kelly Rouster‐Stevens,Nadine Saad,Rayfel Schneider,Velma Selmanovic,Irmina Pasic,Susan Shenoi,Natalie Shilo,Jennifer Soep,Amit Sura,Sarah Taber,Melissa Tesher,Jessica Tibaldi,Kathryn Torok,Cathy Tsin,Natalia Vasquez‐Canizares,D. Villacis-Nunez,Emily Way,Benjamin Whitehead,Lawrence Zemel,Surbhi Sharma,Marcelo Fernández-Viña
+80 authors
,Elizabeth MellinsPublished
Jul 1, 2024
Show more
Save
Tip0
TipSave
Abstract
After introducing IL-1/IL-6 inhibitors, some patients with Still and Still-like disease developed unusual, often fatal, pulmonary disease. This complication was associated with scoring as DReSS (drug reaction with eosinophilia and systemic symptoms) implicating these inhibitors, although DReSS can be difficult to recognize in the setting of systemic inflammatory disease.
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.